Invicta Diagnostic Peer Comparison

NSE: INVICTA

₹70.00

₹0.00 (0.00%)

As on 28-Aug-2026 12:04IST

Market cap

₹88 Cr

Revenue (TTM)

₹30 Cr

P/E Ratio

17.9

P/B Ratio

1.7

Div. Yield

0 %

Edit

	Invicta Diagnostic	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
Market cap (₹ Cr)	88	39,538	32,407	32,332	14,953
Revenue (₹ Cr)	30	4,683	2,891	4,213	857
Net Profit (₹ Cr)	4.93	552.34	546.30	190.80	187.49
Net Margin (%)	16.33	11.55	18.23	4.49	21.32
RoE (%)	40.48	14.93	23.03	9.45	20.58
Price to Earnings	17.94	71.09	59.80	158.26	79.76
Price-To-Book	1.71	9.62	12.40	8.54	14.85

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Invicta Diagnostic	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
Operating Revenue	30.10	3,692.35	2,461.40	3,035.10	681.39
Total Income	30.18	3,797.15	2,554.83	3,067.00	699.71
Total Expenditure	20.90	2,831.90	1,765.80	2,242.10	408.17
EBITDA	9.20	860.44	695.60	793.00	273.22
Depreciation	2.49	193.75	141.92	177.20	70.60
EBIT	6.71	666.69	553.67	615.80	202.62
Interest	0.23	74.35	22.31	100.40	26.74
Other Income	0.09	104.81	93.43	31.90	18.32
Exceptional Items	--	-49.90	--	10.80	-1.03
Profit before Tax	6.56	647.26	624.80	558.10	193.16
Provision for Tax	1.63	165.94	132.55	143.30	49.37
Profit after Tax	4.93	481.32	492.25	414.80	143.79

Liabilities (₹ Cr)

	Invicta Diagnostic	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
Shareholder's Funds	14.62	3,386.41	2,172.72	2,137.80	799.14
Minority Interest	-1.03	1.10	33.76	281.00	--
Non-Current Liabilities	4.92	726.88	21.34	2,421.10	311.86
Current Liabilities	2.70	618.82	402.35	836.20	162.61
Total Liabilities	21.22	4,766.23	2,713.41	5,689.20	1,273.62

Assets (₹ Cr)

	Invicta Diagnostic	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
Non-Current Assets	14.83	3,200.08	1,266.66	4,978.80	966.41
Current Assets	6.39	1,533.12	1,363.51	697.30	307.21
Total Assets	21.22	4,766.23	2,713.41	5,689.20	1,273.62
Total Debt*	3.54	327.88	0.00	1,910.90	0.00
Net Current Assets	3.69	914.31	961.16	-138.90	144.59
Contingent Liabilities	--	88.77	10.59	83.80	0.13

Cashflow (₹ Cr)

	Invicta Diagnostic	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
Cash From Operating Activities	6.56	623.76	568.89	581.80	224.47
Cash Flow from Investing Activities	-5.23	-720.94	-303.16	-1,116.20	-181.88
Cash from Financing Activities	-0.50	-97.23	-334.03	543.10	-52.05
Net Cash Inflow / Outflow	0.83	-194.41	-68.31	8.70	-9.45

Ratios

Profitability Ratios

	Invicta Diagnostic	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
ROCE (%)	42.85	20.50	31.53	19.02	30.20
ROE (%)	40.48	15.31	25.15	20.92	19.99
ROA (%)	26.57	10.72	19.53	8.74	12.76
EBIT Margin (%)	30.85	26.14	32.06	27.18	42.79
Net Margin (%)	16.33	12.68	19.27	13.52	20.55
Cash Profit Margin (%)	24.66	18.28	25.76	19.51	31.46

Growth Ratios

	Invicta Diagnostic	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
Revenue Growth (%)	90.11	12.74	10.54	21.49	24.39
EBIT Growth (%)	29.78	9.24	16.31	24.83	20.61
Net Profit Growth (%)	29.54	0.68	35.87	23.49	20.19
EPS Growth (%)	30.01	0.65	35.99	24.03	20.67
Book Value Growth (%)	50.26	16.71	17.68	16.93	19.36

Valuation Ratios

	Invicta Diagnostic	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
Price / Earnings	0.00	66.85	21.26	66.51	71.86
Price / Book Value	0.00	9.50	9.79	11.96	13.20
Dividend Yield (%)	--	0.04	0.97	0.00	0.20
EV/EBITDA	1.05	32.52	25.19	33.22	35.28
Market Cap (₹ Cr)	0.00	32,181.74	20,714.85	25,571.93	10,333.01

Solvency Ratios

	Invicta Diagnostic	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
Debt to Equity	0.24	0.10	0.00	0.89	0.00
Short term debt to equity ratio	--	--	--	0.06	--
Current Ratio	2.37	2.48	3.39	0.83	1.89
Quick Ratio	2.18	2.37	3.30	0.76	1.86
Interest Coverage	29.51	9.71	29.01	6.56	8.22

Operating Efficiency Ratios

	Invicta Diagnostic	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
Debtors to sales (%)	4.84	7.90	3.58	13.03	2.17
Asset Turnover	1.62	0.82	0.98	0.64	0.60
Receivable days	14.01	25.07	12.27	41.48	8.30
Inventory Days	5.44	6.62	5.45	6.82	2.71
Payable days	-3,135.74	79.17	134.04	135.60	142.28
Cash Conversion Cycle	3,155.19	-47.48	-116.32	-87.31	-131.27